113 related articles for article (PubMed ID: 11819185)
1. Electronic monitoring: adherence assessment or intervention?
Wagner GJ; Ghosh-Dastidar B
HIV Clin Trials; 2002; 3(1):45-51. PubMed ID: 11819185
[TBL] [Abstract][Full Text] [Related]
2. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries.
Wagner GJ
AIDS Patient Care STDS; 2002 Dec; 16(12):599-608. PubMed ID: 12542933
[TBL] [Abstract][Full Text] [Related]
3. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
[TBL] [Abstract][Full Text] [Related]
4. Sequential antiretroviral adherence measurement using electronic bottle cap monitors in a cohort of HIV-infected adults.
Shuter J; Sarlo JA; Stubbs RO; Rode RA; Zingman BS
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):94-7. PubMed ID: 22223595
[TBL] [Abstract][Full Text] [Related]
5. Use of electronic monitoring induces a 40-day intervention effect in HIV patients.
Deschamps AE; Van Wijngaerden E; Denhaerynck K; De Geest S; Vandamme AM
J Acquir Immune Defic Syndr; 2006 Oct; 43(2):247-8. PubMed ID: 17003672
[No Abstract] [Full Text] [Related]
6. Placebo practice trials: a tool to assess and improve adherence readiness.
Wagner G; Iguchi M; Schneider S; Scott J; Anderson D
HIV Clin Trials; 2002; 3(6):475-81. PubMed ID: 12501131
[TBL] [Abstract][Full Text] [Related]
7. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
[TBL] [Abstract][Full Text] [Related]
8. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment.
Andrade AS; McGruder HF; Wu AW; Celano SA; Skolasky RL; Selnes OA; Huang IC; McArthur JC
Clin Infect Dis; 2005 Sep; 41(6):875-82. PubMed ID: 16107989
[TBL] [Abstract][Full Text] [Related]
9. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
10. Measuring medication adherence: are missed doses reported more accurately then perfect adherence?
Wagner GJ; Rabkin JG
AIDS Care; 2000 Aug; 12(4):405-8. PubMed ID: 11091773
[TBL] [Abstract][Full Text] [Related]
11. Placebo practice trials: the best predictor of adherence readiness for HAART among drug users?
Wagner G
HIV Clin Trials; 2003; 4(4):269-81. PubMed ID: 12916013
[TBL] [Abstract][Full Text] [Related]
12. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with accurate self-reported adherence to HIV antiretrovirals.
Kimmerling M; Wagner G; Ghosh-Dastidar B
Int J STD AIDS; 2003 Apr; 14(4):281-4. PubMed ID: 12716500
[TBL] [Abstract][Full Text] [Related]
14. Predictors of short-term success of antiretroviral therapy in HIV infection.
Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
[TBL] [Abstract][Full Text] [Related]
15. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial.
Weber R; Christen L; Christen S; Tschopp S; Znoj H; Schneider C; Schmitt J; Opravil M; Günthard HF; Ledergerber B;
Antivir Ther; 2004 Feb; 9(1):85-95. PubMed ID: 15040540
[TBL] [Abstract][Full Text] [Related]
16. Validity of a stage of change instrument in assessing medication adherence in indigent patients with HIV infection.
Rathbun RC; Farmer KC; Lockhart SM; Stephens JR
Ann Pharmacother; 2007 Feb; 41(2):208-14. PubMed ID: 17213294
[TBL] [Abstract][Full Text] [Related]
17. Correlates of HIV antiretroviral adherence in persons with serious mental illness.
Wagner GJ; Kanouse DE; Koegel P; Sullivan G
AIDS Care; 2004 May; 16(4):501-6. PubMed ID: 15203417
[TBL] [Abstract][Full Text] [Related]
18. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial.
Sorensen JL; Haug NA; Delucchi KL; Gruber V; Kletter E; Batki SL; Tulsky JP; Barnett P; Hall S
Drug Alcohol Depend; 2007 Apr; 88(1):54-63. PubMed ID: 17056206
[TBL] [Abstract][Full Text] [Related]
19. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study.
Rathbun RC; Farmer KC; Stephens JR; Lockhart SM
Clin Ther; 2005 Feb; 27(2):199-209. PubMed ID: 15811483
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.
Wohl AR; Garland WH; Valencia R; Squires K; Witt MD; Kovacs A; Larsen R; Hader S; Anthony MN; Weidle PJ
Clin Infect Dis; 2006 Jun; 42(11):1619-27. PubMed ID: 16652320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]